大和:上調新華保險(1336.HK)目標價至35港元 評級“優於大市”
大和上調新華保險(1336.HK)評級至“優於大市”,目標價上調至35港元。大和發表報告表示,新華保險是對A股變動最敏感的股票之一,可受惠近期A股上漲,加上公司第二季新業務增長或高於行業平均水平,將其評級由“持有”升至“優於大市”,目標價亦由26港元,上調34.6%至35港元。
該行表示,據估算,A股市場每上漲1%,就能使得新華保險的企業價值上升0.3%,淨利潤增加8%。中國境內債收益率回升,導致新投資回報逐漸恢復,新華保險受益明顯。
大和又稱,新華保險4月及5月的保費增速高於上市同行的平均水平,預計公司第二季度第一年度保費將實現雙位數的按年增長。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.